Last reviewed · How we verify

NCT03257514

Effect of Alpha Lipoic Acid on Uterine Scar Healing After Cesarean Section

Completed Phase 2 Last updated 8 March 2018
What this trial tests

Phase 2 trial testing alpha lipoic acid drug (thioctic acid acid) in Cesarean Section; Dehiscence in 102 participants. Completed in 1 February 2018.

Timeline
1 June 2017
Primary endpoint
1 January 2018
1 February 2018

Quick facts

Lead sponsorAin Shams University
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment102
Start date1 June 2017
Primary completion1 January 2018
Estimated completion1 February 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 35, female only, with Cesarean Section; Dehiscence or Cesarean Scar Niche. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the efficacy of alpha lipoic acid on uterine scar healing after cesarean section by using saline contrast sonohysterography

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cesarean Section; Dehiscence

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03257514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing